21 January 2018
News and Views
Links and Services
August's issue of the Alimentary Pharmacology & Therapeutics evaluates the treatment of ulcerative colitis with adalimumab and infliximab.
Randomized, controlled trials have demonstrated that anti-TNF agents are efficacious in inducing
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors